Otherwise, the upregulation of both ZO-1 and occludin expression significantly improves the integrity, reduces the intestinal mucosal barrier permeability, and prevents the infiltration of harmful substances in IBD patients (7, 8). The gene discussed is OCLN; the disease is inflammatory bowel disease.